Analysis of Chinese inositol exports

Oct 14
22:44

2013

David Yvon

David Yvon

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Inositol has the role of lower cholesterol, prevent hair loss, prevent eczema and so on. Extraction of inositol is generally from the animal's liver, brewer's yeast, bovine brain and heart, United States melon, grapefruit, grape plum, malt, unrefined molasses, peanuts and cabbage, whole grain cereals, etc.

mediaimage

And the raw material for producing inositol is phytine,Analysis of Chinese inositol exports Articles phytine is mostly extracted from water of rice bran and corn dip.

 

In 2012, Chinese inositol export volume rose 19.58% on year-on-year basis, export prices fell by an average of 18.07%, and exports down by 2.03%. China is producing and exporting country of inositol, starting from 2003, affected by rising costs, raw materials rise in price, energy and labor costs are increasing as well as the appreciation of the renminbi and other factors, inositol export prices continued to rise in China, but impacted by the crisis of the second half of 2008, the international demand was weakened. In addition, under the influence of excess production capacity and raw material at a reduced prices and other factors stacking, Chinese inositol export prices declined like "a roller coaster", first dropped nearly half, part of inositol production companies will have to take the limited production or stop production measures to cope with the rapid changes market at that time, After the market gradually warming, inositol's export prices remain stable, while exports continued to increase, reaching a record high in 2012, up to 4,156 tons.

 

China's main export market of inositol is European Union, ASEAN and North America and other countries and regions. In 2012, Chinese exports of inositol to the European Union was grew 32.14% on year-on-year basis, the average export price fell 15.87%, exports accounted for 32.58% of China's total inositol exports; exports to North American was increased by 19.93%, the average export price fell 21.43%, the exports accounted for 22.29% of Chinese inositol in foreign exports; exports to ASEAN grew 22.6%, the average export price fell 18.47%, exports accounted for 23.69% of Chinese inositol in foreign exports.

 

Chinese inositol exports to Germany, Belgium, Brazil and South Korea are with higher prices, in 2012 was respectively reached at $9,860 per ton, $9,190, $9,080 and $9,050; in 2012, Chinese inositol exports to Germany and Belgium was rapidly growing, while the larger declined  markets are the Netherlands, Brazil and Chile.

 

In 2012, there are a total of 17 provinces in China engaged in inositol exports, of which Jiangsu, Shandong are with higher export price, in 2012, it was respectively $9,990 per ton, $9,050, the larger export volume areas are Henan, Liaoning and Zhejiang provinces.

 

As the demand of inositol growing in recent years, its production model is also continuous improvement and innovation. The traditional mode of production has been the pressure hydrolysis, then developed the phytate hydrolysis process, product quality meets the drugs targets specified. While the developed pressure catalytic processes in recent years, the quality of the finished inositol product even reached the U.S. pharmaceutical standards. In addition, Japan's patented technology in this regard have the simplification process, small number of labor, lower production costs, high inositol yield. The products do not through crude product stage, directly produce quality products, quality can be achieved U.S. pharmaceutical standards.

 

According to pharmaceutical raw materials suppliers, inositol is widely used in medicine and health food and other fields. Especially in recent years, both the Chinese and international markets, paclitaxel has been in short supply, but clinical researches found that the chemical synthesized paclitaxel for the treatment of cancer was less effective, after with inositol modified, the effect of treating cancer is better than natural products. Which is became inositol's new consumption point in today's pharmaceutical industry. Expected in the future period of time, inositol market is still continued to be optimistic.

 

Article Source:http://www.cospcn.com